Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Pamidronate Infusion In Patients With Systemic Sclerosis Results In Changes In Blood Mononuclear Cell Cytokine Profiles.


  • Please log in to reply
No replies to this topic

#1 Guest_Sherrill_*

Guest_Sherrill_*
  • Guests

Posted 23 March 2007 - 06:33 PM

Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.A single infusion of pamidronate was given to patients with systemic sclerosis (scleroderma, SSc) to assess effects on cytokine production by peripheral blood mononuclear cells (PBMC) and lymphocyte subsets. The effects of pamidronate on modulation of cytokine profiles in patients with SSc may merit future study. PubMed. Clin Exp Immunol. 2006 Dec;146(3):371-80. (Also see: Scleroderma Treatments and Causes of Scleroderma: Cytokines)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information. http://www.sclero.org/news/a-to-z.html